PD-1 antibody drug

Recent Articles

RELATED ARTICLES

  1. Hutchmed has reported sharply reduced profits, coming off an exceptionally high base last year, but sales of its key cancer medicine are accelerating in the United States.
    Hutchmed scores U.S. success with cancer drug, but profits still dip
    HCM.US 0013.HK
  2. Novel drugs lift Sino Biopharm earnings, easing price-cap pain
    1177.HK
  3. CSPC Pharma weighs up diet drug for bigger bottom line
    1093.HK
  4. Akeso marks profit milestone with swift rights issue
    9926.HK
  5. Innovent Bio hopes for plus-sized profits from obesity drug
    1801.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva